Black Rock Inc. Athersys, Inc Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.17 - $4.5 $458,590 - $12.1 Million	-2,697,592 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.18 - $0.86 $1.9 Million - $9.07 Million	-10,551,872 Reduced 79.64%	2,697,592 $701,000
Q1 2022 May 12, 2022	SELL	$0.6 - $1.06 $409,951 - $724,248	-683,253 Reduced 4.9%	13,249,464 $8.02 Million
Q4 2021 Feb 10, 2022	SELL	$0.85 - $1.4 $482,690 - $795,019	-567,871 Reduced 3.92%	13,932,717 $12.6 Million
Q3 2021 Nov 09, 2021	BUY	$1.33 - $1.77 $297,189 - $395,508	223,451 Added 1.57%	14,500,588 $19.3 Million
Q2 2021 Aug 11, 2021	BUY	$1.41 - $1.94 $20.1 Million - $27.7 Million	14,277,137 New	14,277,137 $20.6 Million

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.